Robert Allen, Ph.D.
About
Dr. Robert Allen, Ph.D. has built a robust career spanning over 30 years in infectious disease research, anchored by his strong academic background from Rhodes College, Georgia Institute of Technology, and Columbia University.
Prior to his role at IVVD, he held senior scientific positions at organizations such as SmartPharm Therapeutics and Sorrento Therapeutics, as well as other industry-leading institutes like SIGA Technologies, honing his expertise in virology and immunotherapy.
Since joining IVVD as Chief Scientific Officer on April 11, 2023, he has played a critical role in steering the company’s research initiatives, including the development of gene-encoded monoclonal antibodies for COVID-19.
His extensive experience and leadership in the biopharmaceutical sector underscore a career dedicated to advancing innovative therapeutic solutions, making him a key asset in the company's strategic pursuits.